Citations for
1AHBBD, YY1AP1
Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.
Guo DC, Duan XY, Regalado ES, Mellor-Crummey L, Kwartler CS, Kim D, Lieberman K, de Vries BB, Pfundt R, Schinzel A, Kotzot D, Shen X, Yang ML; University of Washington Center for Mendelian Genomics.
Am J Hum Genet 100(1):21-30. doi: 10.1016/j.ajhg.2016.11.008. 2017
2YY1AP1
Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma.
Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW.
Oncogene 34(39):5095-104. doi: 10.1038/onc.2014.438. 2015
3MAD2L2, YY1AP1
Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2.
Li L, Shi Y, Wu H, Wan B, Li P, Zhou L, Shi H, Huo K.
Mol Cell Biochem 304(1-2):297-304. 2007
4NPPA, TBX5, WWTR1, YY1AP1
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.
Murakami M, Nakagawa M, Olson EN, Nakagawa O.
Proc Natl Acad Sci U S A 102(50):18034-9. Epub 2005 Dec 6. 2005
5YY1, YY1AP1
YY1AP, a novel co-activator of YY1.
Wang CY, Liang YJ, Lin YS, Shih HM, Jou YS, Yu WC.
J Biol Chem 279(17):17750-5. 2004
6YY1AP1
[Clone of a novel liver cancer associated gene and analysis of the secondary structures of the predicted protein]
Wang Z, Hu G, Wang H, Wu M.
Zhonghua Gan Zang Bing Za Zhi 10(1):25-7. Chinese. 2002
7YY1AP1
Identification and characterization of a novel human hepatocellular carcinoma-associated gene.
Wang ZX, Wang HY, Wu MC.
Br J Cancer 85(8):1162-7. 2001